Chapter 4
Kill All the Lawyers?
How to Immunize Your Company from Class-Action Lawsuits
In This Chapter
- Surprising trends in shareholders' lawsuits.
- A sharp price drop—not enough to get you sued.
- The profile of likely litigation targets.
- Lawsuit immunization policies.
Shareholder lawsuits, many believe, are seriously harming the U.S. economy.1 John Thain, former CEO of the New York Stock Exchange (NYSE) (later of Merrill Lynch, until his resignation in 2009) joined the chorus of U.S. business leaders blaming, in part, the prevalence of shareholder lawsuits for the increasing number of companies registering abroad. Thain told the Financial Times: “the high risk of litigation [in the United States] compared with other jurisdictions remained ...
Get Winning Investors Over now with the O’Reilly learning platform.
O’Reilly members experience books, live events, courses curated by job role, and more from O’Reilly and nearly 200 top publishers.
